NASDAQ:IMVT | Profit Breakdown | Immunovant, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2018-06-30 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$153.22M-$153.22M
2026-03-31-$150.7M-$147.86M
2025-12-31-$109.08M-$110.64M
2025-09-30-$125.91M-$126.5M
2025-06-30-$119.7M-$120.61M
2025-03-31-$105.87M-$106.45M
2024-12-31-$110.97M-$111.12M
2024-09-30-$109.04M-$109.12M
2024-06-30-$87.07M-$87.15M
2024-03-31-$75.09M-$75.32M
2023-12-31-$51.53M-$51.42M
2023-09-30-$58.21M-$58.66M
2023-06-30-$73.95M-$73.94M
2023-03-31-$60.42M-$59.43M
2022-12-31-$62.84M-$63.23M
2022-09-30-$47.67M-$47.93M
2022-06-30-$40.02M-$40.37M
2022-03-31-$47.18M-$47.17M
2021-12-31-$41.39M-$41.39M
2021-09-30-$37.73M-$37.7M
2021-06-30-$30.51M-$30.47M
2021-03-31-$28.24M-$28.16M
2020-12-31-$32.14M-$31.78M
2020-09-30-$20.75M-$20.79M
2020-06-30-$26.66M-$26.71M
2020-03-31-$20.61M-$20.55M
2019-12-31-$11.2M-$11.3M
2019-09-30-$419,757.00-$14.45M-$14.48M
2019-06-30-$92,342.00-$20.04M-$20.06M
2019-03-31-$9.03M-$9.03M
2018-12-31-$8.84M-$8.85M
2018-09-30-$6.35M
2018-06-30-$4.37M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-03-31-$505.39M-$505.61M
2025-03-31-$412.95M-$413.84M
2024-03-31-$258.77M-$259.34M
2023-03-31-$210.95M-$210.96M
2022-03-31-$156.81M-$156.73M
2021-03-31-$107.79M-$107.43M
2020-03-31-$66.29M-$66.39M
2019-03-31-$28.58M-$28.6M